Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. - Wikidata - awgldk - TriplyDB

Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population.

Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population.

http://www.wikidata.org/entity/Q37103777

about

The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer.Metabolome-based biomarkers: their potential role in the early detection of lung cancer

P2860

Q30313659-6EA5950A-77FB-4E86-908B-D4E0F24447E7 Q59129088-2B751396-3C0A-499B-8891-3E3402734BCF

P2860

Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population.

http://www.wikidata.org/entity/Q37103777

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Plasma osteopontin velocity di ...... in a CT screening population.

@en

Plasma osteopontin velocity di ...... in a CT screening population.

@nl

type

label

Plasma osteopontin velocity di ...... in a CT screening population.

@en

Plasma osteopontin velocity di ...... in a CT screening population.

@nl

prefLabel

Plasma osteopontin velocity di ...... in a CT screening population.

@en

Plasma osteopontin velocity di ...... in a CT screening population.

@nl

P1433

Q37103777-0D9DAC80-E124-4541-A535-C25C27C0ECDB

P1476

Q37103777-395D4390-7637-4E97-ACDF-0B552DA4E652

P2093

Q37103777-0466C08E-0D82-44DB-8828-FB3E0152089F

Q37103777-0DFB8A22-FA78-449F-8C47-AC0301516A12

Q37103777-11483430-E6AD-4585-8DCB-4D8C8397005F

Q37103777-12118301-0231-4461-A10E-1CB3B9B2119C

Q37103777-1E5D3660-FC92-40BA-80BD-2A9A64603243

Q37103777-4D27C963-FBB7-44C9-BC3A-8EA50A19FE79

Q37103777-85FE7D78-A587-441C-AC18-373D72583517

Q37103777-B8987C69-5CD1-4590-9C4C-74DBB711D353

Q37103777-BCAFDF22-D928-46F5-BE9B-28D77D407A3E

Q37103777-D83943AF-1F00-4C17-9901-562817313D78

P2860

Q37103777-16B92466-EEED-4F0A-A33E-3B491EA32F88

Q37103777-253F3A74-BDC0-4C98-999A-668BEEB2AFCE

Q37103777-363CFF76-89BE-49E3-A0E0-14CA8C3162E7

Q37103777-3C387602-CDCB-4AF5-956E-A374540D6C76

Q37103777-3F37D4C0-E08F-468E-80EC-B7A461C3F322

Q37103777-4414263A-4932-4A9F-B919-FF0C478A1521

Q37103777-4860C18F-9D69-4ABA-9CEA-9624BA2317DC

Q37103777-547FAA54-D4A5-446C-8791-6852FF29935F

Q37103777-62AD1BFF-B2E1-4E12-A2FF-27EB4AF032C3

Q37103777-6FE0C92C-5105-4B0C-8EC2-C44052CDA04B

P304

Q37103777-71FFD75D-9E8C-44BF-B003-833974BB46FC

P31

Q37103777-38259C05-9667-4AA6-9760-58ECEA1EF8EE

P356

Q37103777-E07F2DB8-0201-44BE-A1B3-B98BDE72FB09

P433

Q37103777-09659E28-3788-4623-B365-1AA1632429F9

P478

Q37103777-EC9501BF-367F-4D09-841C-BDDE6961B7E0

P50

Q37103777-D57AA0DC-B298-4BB6-9A02-E75404178936

Q37103777-D818ABCE-B964-49C9-844E-460F8A3B928B

P577

Q37103777-EF55D3B4-3DC1-4D9C-BB65-5028D76D6312

P698

Q37103777-D374E711-6CB0-49E4-BEFB-C4FA3E97C96C

P932

Q37103777-5121A3D3-E0CB-407A-85F6-A30AD329AB94

P356

P1433

Cancer Biomarkers

P1476

Plasma osteopontin velocity di ...... s in a CT screening population

@en

P2093

Amanda Beck

http://www.w3.org/2001/XMLSchema#string

Dawn Walter

http://www.w3.org/2001/XMLSchema#string

Jessica Donington

http://www.w3.org/2001/XMLSchema#string

Justin Blasberg

http://www.w3.org/2001/XMLSchema#string

Mark Slomiany

http://www.w3.org/2001/XMLSchema#string

Nathalie Hirsch

http://www.w3.org/2001/XMLSchema#string

Ryan Harrington

http://www.w3.org/2001/XMLSchema#string

Sasha Joseph

http://www.w3.org/2001/XMLSchema#string

Tyler Litton

http://www.w3.org/2001/XMLSchema#string

William Rom

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society 1

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

Cancer statistics, 2010

The role of osteopontin in lung disease

Reduced lung-cancer mortality with low-dose computed tomographic screening

Survival of patients with stage I lung cancer detected on CT screening

Mass screening for lung cancer with mobile spiral computed tomography scanner

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Screening and prostate-cancer mortality in a randomized European study

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

P304

177-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-130306

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Judith D Goldberg

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23568008

http://www.w3.org/2001/XMLSchema#string

P932

3746829

http://www.w3.org/2001/XMLSchema#string